Back to Search
Start Over
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: <scp>Three‐Year</scp> Results From a Phase <scp>IIb</scp> Randomized Controlled Trial and Its <scp>Open‐Label</scp> Extension Study
- Source :
- Arthritis & Rheumatology. 74:1943-1958
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Rheumatology
Immunology
Immunology and Allergy
Subjects
Details
- ISSN :
- 23265205 and 23265191
- Volume :
- 74
- Database :
- OpenAIRE
- Journal :
- Arthritis & Rheumatology
- Accession number :
- edsair.doi...........25e76774203c39795c4de44e7ab36721